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MINI-REVIEWProgress of CRISPR-Cas Based Genome Editing in
Photosynthetic MicrobesMihris Ibnu Saleem Naduthodi, Maria J. Barbosa, and John van der Oost*The carbon footprint caused by unsustainable development and its environ-
mental and economic impact has become a major concern in the past few
decades. Photosynthetic microbes such as microalgae and cyanobacteria are
capable of accumulating value-added compounds from carbon dioxide, and
have been regarded as environmentally friendly alternatives to reduce the
usage of fossil fuels, thereby contributing to reducing the carbon footprint.
This light-driven generation of green chemicals and biofuels has triggered the
research for metabolic engineering of these photosynthetic microbes.
CRISPR-Cas systems are successfully implemented across a wide range of
prokaryotic and eukaryotic species for efficient genome editing. However, the
inception of this genome editing tool in microalgal and cyanobacterial species
took off rather slowly due to various complications. In this review, we
elaborate on the established CRISPR-Cas based genome editing in various
microalgal and cyanobacterial species. The complications associated with
CRISPR-Cas based genome editing in these species are addressed along with
possible strategies to overcome these issues. It is anticipated that in the near
future this will result in improving and expanding the microalgal and
cyanobacterial genome engineering toolbox.1. Introduction
The exploitation of non-renewable energy sources to meet the
perpetual requirement of increasing human population has
resulted in their rapid depletion and a steady rise in price.
Moreover, their uncontrolled usage has resulted in an elevated
CO2 concentration in the atmosphere, resulting in global
warming and associated problems. In this scenario, it is of
utmost importance to ﬁnd environmentally friendly alternativesM. I. S. Naduthodi, Prof. J. van der Oost
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world. The potential of deploying photo-
synthetic microbes such as microalgae and
cyanobacteria for production of next gen-
eration fuels is being studied extensively.[1]
The ability to ﬁx CO2 and convert it into
value added compounds without compet-
ing with food and feed crops make these
green microbes promising biofuel produc-
ing organisms from an environmental
perspective.[2] However, studies on micro-
algae to exploit their complete potential for
commercial application has not proceeded
fast mainly because of the lack of industrial
strains. Efﬁcient genome editing tools for
microalgae are still lacking. Conventional
homologous recombination-based gene
editing was reported in genera like Nanno-
chloropsis andOstreococcus. The Zinc Finger
Nucleases (ZFN) were applied in Chlamy-
domonas reinhardtii for achieving targeted
gene editing, while Transcription Activator
Like Effector Nucleases (TALEN) were
implemented in Phaeodactylum tricornu-
tum.[3] Nevertheless, the labor intensive-
ness, complexity and high cost forapplication was a bottleneck for implementing ZFN and TALEN
for genome engineering. Since 2014, CRISPR-Cas based
genome editing has been reported in various microalgal species,
which will be the prime focus of this review.[4]
The genome editing of both prokaryotes and eukaryotes has
been simpliﬁed with the introduction of RNA guided nucleases
of CRISPR-Cas systems (Clustered regularly interspaced short
palindromic repeats and associated proteins).[5,6] These endo-
nucleases use short CRISPR-derived RNA guides to target
complementary DNA. After recognition of a protospacer
adjacent motif (PAM) sequence positioned next to the target
sequence, the Cas nuclease (Cas9, Cpf1/Cas12a) introduces
double strand DNA breaks (DSBs). Mutating the catalytic active
site of Cas9 protein results in a dead Cas9 (dCas9)[7] that has been
implemented for CRISPR interference (CRISPRi) by stably
binding, for instance to the promoter region of a target gene, and
thereby downregulating the transcription of a target gene.[7,8]
The CRISPR systems are divided into twomajor classes based on
their architecture: class I systems (types I, III, and IV) formmulti
subunit protein crRNA-binding nuclease complexes, and class II
system (type II,V and VI) consist of a single guide-binding
nuclease protein.[9] Initially, the Cas9 from Streptococcus pyogenes
(SpCas9, archetype of the type II CRISPR-Cas system) and
related Cas9 variants have been widely applied for genomenal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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www.advancedsciencenews.com www.biotechnology-journal.comengineering. Recently, Cas12a (Cpf1) of the type V system is also
gaining global attention for genome editing in various
species.[10–12] Cas12a is an interesting alternative tool for
genome engineering as it has distinct features compared to
Cas9 (Figure 1), such as (i) Cas12a uses a single crRNA instead of
a set of crRNA and trans-activating crRNA (tracrRNA) in Cas9
that is synthetically fused as a single guide RNA (sgRNA) that is
at least twice as long as the crRNA guide used by Cas12a, (ii)
Cas12a has been demonstrated to catalyze the maturation of its
own crRNA which allows for efﬁcient multiplex genome
editing,[12,13] while maturation of crRNA:tracrRNA complex of
Cas9 relies on processing by the non-Cas ribonuclease RNase III,
(iii) Cas12a uses a T-rich PAM (50-TTTN-30) upstream the
protospacer in contrast to the downstream located G-rich PAM
(50-NGG-30) that is recognized by Cas9,[11] (iv) Cas12a generates
staggered ends with ﬁve nucleotide overhangs in the target DNA,
compared to the blunt end cleavage by Cas9,[11,14] (v) Cas12a has
a single nuclease domain (RuvC) that cleaves 18–23 base pairs
downstream from the PAM-proximal seed sequence, whereas
cleavage by the two nuclease domains of Cas9 (RuvC and HNH)
occurs within the seed three base pairs upstream its PAM
(Figure 1). These mechanistic differences may have important
practical advantages, such as directly using small (42–66 nt),
commercially-produced crRNA guides, and the potential to
perform multiplex genome editing owing to the self-maturation
of a precursor crRNA guide. In addition, it has been proposed
that the fact that Cas12a cleavage occurs outside its seed region
(Figure 1),[11] may enhance the frequency of HDR as the seed
sequence is not destroyed by Non-Homologous End Joining
(NHEJ) in eukaryotes, and hence cleavage could continue after
NHEJ repair until HDR is successful (substituting essential
nucleotides in PAM and/or seed). This review elaborates on
the application of CRISPR-Cas based genome engineering
in microalgae and cyanobacteria, and provides insights on
strategies to enhance efﬁciency of the CRISPR-Cas tools for
generating targeted mutants in these microbes (Table 1).John van der Oost obtained his PhD
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Argonaute).2. Chlamydomonas reinhardtii
The completely sequenced and annotated genome, the genetic
accessibility, the ease of generating and screening mutants
owing to its haploid nature and decades of research on cellular
and molecular level has made Chlamydomonas reinhardtii an
exceptional model organism in the ﬁeld of micro-algal
research.[15] The ﬁrst CRISPR-Cas9 based genome editing in
microalgae was reported in C. reinhardtii.[4] Plasmid-based
delivery of a codon optimized SpCas9 gene and speciﬁc sgRNAs
to Chlamydomonas reinhardtii has resulted in transient expres-
sion and targeting restriction sites of various exogenous genes.[4]
The exogenous target gene as well as the cas9 and sgRNA genes
were delivered into the host on the same plasmid. After
transformation, the target loci were PCR ampliﬁed after which
the obtained amplicons were subjected to restriction digestion
with the enzyme cleaving the target site. Introduction of indels at
the target site by NHEJ upon Cas9 cleavage was hypothesized to
result in the fragments’ resistance to the speciﬁc restriction
digestion. Sequencing of the fragments resistant to this
restriction digestion revealed indels in the region of Cas9 cutBiotechnol. J. 2018, 1700591 1700591 (2 of 9) © 2018 Thesite, conﬁrming Cas9 nuclease activity. However, an experiment
involving multiple transformations and more than 109 cells for
targeting an endogenous gene (FKB12) by Cas9 resulted in a
single mutant colony, demonstrated a rather low efﬁciency ofAuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
Figure 1. Schematic representation of DSB generation by Cas9 and Cas12a, and repair mechanisms present in eukaryotes for restoring the DSB. The
Cas9 causes a blunt end DSB 3 base pairs downstream the PAM 50NGG03 and Cas12a introduce staggered end DSB 18 and 23 base pairs away from the
PAM 50TTTN03 on targeting and non-targeting strands respectively. NHEJ and HDR based repair mechanisms are implemented by eukaryotic cells to
repair the DSBs, where indels and random insertions at repair site by NHEJ results in error prone repair, while HDR repair mechanism is results in
flawless integration or deletion of target site and provides possibilities for errorless targeted genome editing.
www.advancedsciencenews.com www.biotechnology-journal.comthis approach for generating frame-shift mutants. The cytotox-
icity of Cas9 in C. reinhardtii was inferred for this problem as
Western blot analysis failed to detect even minute levels of either
Cas9 or dCas9.[4] Recently, Jiang et al. managed to enhance the
efﬁciency of plasmid-based Cas9 activity in C. reinhardtii by
implementing a hybrid version of Cas9.[16] In this work, a gene-
within-a-gene approach was used in which an artiﬁcial intron
sequence harboring a sgRNA was incorporated into the Cas9
coding sequence. The activity of this system was validated by
restoring the abolished reading frame in an exogenously
supplied mutant antibiotic resistance gene. Indeed, some
recombinants gained the capacity to grow on plates with the
corresponding antibiotic, indicating Cas9 cleavage and repair by
non-homologous end joining (NHEJ).[16] The targeting of the
hybrid Cas9 system was reported to be 50 times more efﬁcient
compared to the previous version, as targeting the same gene
with this approach yielded 13 mutants among 4 108 cells
transformed.[4,16] However, the observation that none of the
mutants obtained by the hybrid-Cas9 approach harbored an
intact Cas9 gene, strongly suggested toxicity of Cas9.[16] In the
same study, it has also been tested to combine homologousBiotechnol. J. 2018, 1700591 1700591 (3 of 9) © 2018 Therecombination and Cas9 nuclease activity to achieve precise,
error-less gene editing. The transformation with the hybrid-Cas9
and short single stranded DNA repair fragments with single
nucleotide mismatches at the Cas9 target site resulted in an
average of six correct mutants upon when two different genes
were targeted independently, whereas no mutants were obtained
when the homologous ssDNA was transformed alone.[16] This
relatively low homologous recombination frequencies in
C. reinhardtii (in the absence of Cas9) were in agreement with
earlier observations.[17] Also, the induction of DSBs has been
reported to enhance the homologous recombination efﬁciency in
various eukaryotes which could have occurred in C. reinhardtii
facilitating the formation of these six expected mutants.[6,18]
The plasmid-based expression of two Cas9 variants (spCas9
from Streptococcus pyogenes and saCas9 from Staphylococcus
aureus) in C. reinhardtii and their efﬁciency in producing indel
mutations was compared by Greiner et al.[19] In the experiment
targeting the PSY1 gene by both Cas9 variants independently,
application of SaCas9 yielded 9% mutants among the entire
antibiotic resistant transformants obtained, outperforming
SpCas9 which yielded 3% mutants. The efﬁciency of targetingAuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
Table 1. Overview of the native genes edited in Photosynthetic microbes using CRISPR-Cas systems.
Species
Strategy for Cas
protein delivery
Outcome of the
target gene Modification at the target site Target genes Ref.
Chlamydomonas
reinhardtii
Plasmid Knockout Indels FKB12, PSY1, ChR2,
COP1/2, COP5, PHOT
[7,34]
HDR ARG7, ALS [28]
RNP Knockout Indels MAA7, CpSRP43, ChlM,
CpFTSY, ZEP, PHT7
[39–
41,71]
HDR aCRY, COP1/2, COP5,
PHOT, UVR8, VGCC,
MAT3, KU80, POLQ
[34]
Plasmid Downregulation None PEPC1 [38]
Nannochloropsis oceanica Plasmid Knockout Indels NR; g7988 [49]
Nannochloropsis
gaditana
Plasmid Disruption NHEJ based insertion of antibiotic
resistant gene cassette
18 different putative
transcriptional regulators
[50]
Phaeodactylum
tricornutum
Plasmid Knockout Indels CpSRP54 [53]
Thalassiosira pseudonana Plasmid Knockout Deletion of a 37 bps fragment in the
coding region of the gene by
simultaneous targeting of 2 regions
on the same gene
URE [60]
Disruption HDR based targeted insertion of
antibiotic resistant gene cassette
Silacidin [60]
Synechocystis sp. PCC
6803
Plasmid Downregulation None phaE, glgC and 4 putative aldehyde
reductases/dehydrogenases
[63]
Knockout HDR nblA and isiA [70]
Synechococcus elongatus
PCC 7942
Plasmid Downregulation None glgC, sdhA, and sdhB [64]
Knockout HDR glgC [67]
Knock in HDR gltA and ppc
Synechococcus sp. PCC
7002
Plasmid Downregulation None cpcB, ccmK1, and glnA [65]
Anabaena sp. PCC 7120 Plasmid Downregulation None glnA and devH [66]
Deletion HDR nifH and nifD [70]
Synechococcus elongatus
UTEX 2973
Plasmid Knockout HDR nblA and psbA1 [68,70]
RNP, ribonucleoprotein; HDR, homology directed repair.
www.advancedsciencenews.com www.biotechnology-journal.comby SaCas9 was further improved to 16% by recovering the cells
after transformation for 1 day at 33 C and another day at 22 C
before transferring to the antibiotic media plate. The expression
of the SaCas9-encoding gene in this experiment was controlled
by the HSP70A promoter that typically upregulates the
expression of downstream genes after short heat shocks
(typically at 40 C).[20] Greiner et al.[19] suggests that the
enhanced efﬁciency in this case could be due to the high
Cas9 expression fromHSP70Apromoter at the elevated recovery
temperature (33 C). Also, SaCas9 derived from the mesophilic
host Staphylococcus aureus with optimal growth temperature
ranging from 37 to 40 C[21] might have its ideal activity at higher
temperatures, thereby contributing to the improved efﬁciency.
Four photoreceptor genes were successfully targeted by this
approach using SaCas9 and, contradictory to SpCas9, intact
sequences of the SaCas9-encoding gene were detected from
engineered strains, most likely suggesting its reduced toxicity.[19]Biotechnol. J. 2018, 1700591 1700591 (4 of 9) © 2018 TheKao et al. performed CRISPRi and observed decaying mRNA
levels of Sp_dCas9 upon sub-culturing of strains up to seven
generations.[22] Linear phenotypic changes were also observed
with gradual recovery of the expression of targeted genes in
subsequent cultures, suggesting decreased expression of the
dCas9 gene in the course of this experiment.[22] These results
differ from the conclusions of Jiang et al., as successful CRISPRi
by Kao et al. indicated effective Cas9 expression. In both the
studies Cas9 proteins were expressed under same promoter and
terminator (Cauliﬂower Mosaic Virus, CMV-35S). Nevertheless,
the Cas9 gene sequences used in the two studies varied up to
14% indicating the effect of codon harmonization on gene
expression in C. reinhardtii.
As an alternative delivery method, the CRISPR-Cas nuclease
proteins puriﬁed from (bacterial) production systems, loaded
with appropriate guides in vitro, after which the obtained
ribonucleoprotein (RNP) complexes can be transformed to theAuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
www.advancedsciencenews.com www.biotechnology-journal.comhost of interest. The fact that bacterial production systems are
used, circumvent codon optimization for each to-be-edited host.
An additional advantage may be that off-target problems are
reduced because of a limited half-life of the RNP complex and
saturation of the Cas protein with pre-loaded guide RNAs.
Indeed, Cas9-RNP delivery to C. reinhardtii has substantially
resolved issues with plasmid-based Cas9 genome editing.[23,24]
Efﬁciency of about 1% in generating indels at chromosomal
target sites was observed by this approach, even though it varied
considerably depending on both the gene targeted and the
guide RNA sequence used.[23–25] Co-transformation of antibiotic
resistance genes along with RNP to enhance the selection of
transformants resulted in NHEJ-based knock in of antibiotic
resistance genes at the target sites.[23] This opens up
opportunities to achieve targeted knock in of gene of interest
either by NHEJ or by Homology Directed Repair (HDR).
Realizing the limited efﬁciency of the plasmid-based approach,
Greiner et al. also adopted the RNP-based approach for targeting
genes which upon disruption could result in non-selectable
phenotypes, such as disruption of photoreceptor genes.[19] To
facilitate HDR and achieve errorless DNA repair at an RNP
target site, various donor species (plasmids, dsDNA and ssDNA)
with 30 bps upstream and downstream homologous ﬂanks were
transformed along with the RNP complexes. The linear dsDNA
template efﬁciently integrated to the cleavage site of RNP by
NHEJ, whereas the ssDNA template recombined less efﬁciently
but with high chances of ﬂawless HDR. The RNP along with
various DNA editing templates were used to disrupt up to eight
genes in C. reinhardtii, and again the efﬁciency of achieving each
mutants appeared to be gene/guide dependent.[19] The Cas12a
RNP was also used for demonstrating its efﬁcacy in C.
reinhardtii.[26] The transformation of Cas12a RNP alone targeting
FKB12 gene depicted targeting efﬁciency of 0.02% similar to
Cas9 RNP. However, remarkable improvement in editing
efﬁciency was observed when ssDNA was co-transformed along
with Cas12a RNA for HDR resulting in 29% transformants and
10% errorless HDR mutants.[26] Apart from FKB12, three other
genes were also targeted with the same approach for obtaining
knockout mutants with an efﬁciency of 0.5 to 16% and errorless
HDR based knockouts with an efﬁciency of 0.1–10%.[26]3. Nannochloropsis spp.
Nannochloropsis spp belonging to the class Eustigmatophyceae
are considered as model micro-algal strains primarily due to
their simple and small genome organization (genome size
approximately 30Mb compared to 120Mb ofC. reinhardtii).[27–29]
The industrial relevance for these organisms arise from their
potential to accumulate large amounts of tri-acylglycerol (TAG)
and poly-unsaturated fatty acids (PUFAs) along with tolerance to
wide environmental conditions, such as temperature and light
variations.[29] Vector driven CRISPR-Cas9 based genome editing
has been reported in Nannochloropsis oceanica and Nannochlor-
opsis gaditana.[30,31] In N. oceanica, the frequency of indel
mutants generated by Cas9 nuclease targeting the nitrate
reductase gene was found to be 1.2% by next generation
sequencing. Correspondingly, screening 300 colonies from the
transformants resulted in only two conﬁrmed mutantsBiotechnol. J. 2018, 1700591 1700591 (5 of 9) © 2018 Theindicating the very low efﬁciency of Cas9 in the strains.[30]
Even though reverse transcriptase PCR indicated stable tran-
scripts of Cas9 gene, Western blot analysis could not validate the
presence of Cas9 protein indicating the toxicity or feeble
expression of Cas9 as observed in C. reinhardtii.[30] In
C. reinhardtii there were knock in events observed at the Cas9
cleavage site after NHEJ repair, this was not revealed by deep
sequencing analysis of N. oceanica mutants.[23,24,30] Instead, up
to 0.3% of the sequenced PCR amplicons of the target site after
transformation did not align with the wild type target site
sequence, which might be random pieces of DNA or the cassette
used for transformation inserted at the target site during NHEJ
repair. The cytotoxic effects of vector driven expression of Cas9
was not observed in N. gaditana cultures, thereby favoring
efﬁcient targeted genome editing in the host.[31] Ajjawi et al.
initially developed a N. gaditana strain named Ng-Cas9þ, that
successfully expressed the Cas9 protein from an integrated
codon harmonized gene. Co-transformation of an sgRNA guide
targeting the gene of interest and a hygromycin resistance
cassette to strain Ng-Cas9þ and subsequent selection for growth
on hygromycin plates resulted in colonies harboring the
hygromycin resistance cassette inserted at the Cas9 cleavage
site.[31] This strategy was used to independently knockdown 18
genes inN. gaditana in search for the negative regulators of lipid
accumulation. Attenuating the transcription factor Zn2Cys6, a
homolog of fungal Zn(II)2Cys6 DNA binding domain protein
using this engineering approach, doubled the lipid production
in N. gaditana.[31] Colony PCR screening of transformants that
appeared on hygromycin plates revealed that the efﬁciency of
obtaining the 18 mutant genes ranged from 6–78%.[31]4. Diatoms
Extending from the equator to regions covered with ice, diatoms
thrive in a wide range of marine ecosystems, contributing
substantially to global photosynthesis.[32] Because of their
natural capability to accumulate value added compounds along
with other environmental and nanotechnology applications,
diatoms are considered industrially important microbes.[32,33]
The development of CRISPR-Cas based tools for diatoms were
aimed towards developing relatively cost effective and easy
genome editing tools for studying fundamental diatom biology
via reverse genetics as a basis for obtaining improved strains for
biotechnology applications.[34] To date, CRISPR-Cas systems has
been reported to be successfully applied in diatoms Phaeodacty-
lum tricornutum and Thalassiosira pseudonana.[34,35] In P.
tricornutum, a codon optimized Cas9 and sgRNA modules were
transformed into the host on the same vector without a selectable
marker. However, a pAF6 plasmid with zeocin resistance was co-
transformed along with Cas9 and sgRNA vector to validate the
transformation. Analysis of the transformants by high resonance
melting analysis combined with sequencing indicated a
mutation frequency of up to 31% for sgRNA targeting the gene
CpSRP54 (chloroplast signal recognition particle 54). Nymark
et al. also reports to have achieved a mutation frequency of
25–63% while targeting two other genes in the same species. As
diatoms are diploid organism, NHEJ repair of a Cas9-dependent
DSB in one allele, may lead to HDR in the other allele, resultingAuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
www.advancedsciencenews.com www.biotechnology-journal.comin identical bi-allelic mutants.[34] Presence of mixed mutants
have been observed in some of the colonies which was
hypothesized to be due to the occurrence of cell division prior
to initial mutation event.[34]
Unlike the electroporation transformation used in
Chlamydomonas and Nannochloropsis, biolistic bombardment
was used for transformation of diatoms which could fragment
the vectors resulting in incomplete introduction of Cas9 gene
into the host.[34–36] Also, co-transformation of selectable and
non-selectable vectors has resulted in 40% of the transformants
to harbor only the plasmid with selectable marker.[37] To partially
resolve these issues, in T. pseudonana, the human codon
optimized cas9 gene reported to work in plants[38] and two
sgRNAs targeting 37 nucleotides apart on the urease gene were
transformed on a plasmid also harboring an antibiotic resistance
marker.[35] After transformation by micro-particle bombard-
ment, only 12% (4/33) of the obtained colonies harbored an
intact cas9 gene; all the colonies in which the cas9 gene was
present did have mutations at the target site.[35] Out of the four
colonies (M1,M2,M3 and M4) screened by PCR, the M4 colony
was found to be a clean mutant with 37nt deletion between the
two target sites. TheM2 andM3 colonies showed the presence of
both wild type and mutants with 37nt deletion which was
conﬁrmed to be mosaic colonies upon screening the sub-clones.
Sequence analysis of the M1 colony revealed the presence of a
mono-allelic 4 bp deletion at one of the sgRNA cleavage sites.[35]
Overall, the fact that the majority of the mutants were bi-allelic
with the designed 37 bp deletion,[35] indicates efﬁcient Cas9
editing in T. pseudonana. The promising Cas9 activity in T.
pseudonana was applied to achieve efﬁcient HDR and efﬁciently
obtain designed mutants.[39] Co-transforming the Cas9 and
sgRNA on one plasmid with an editing template harboring
>500 bp upstream and downstream homologous sequences and
an antibiotic resistance marker between the homologous ﬂanks
successfully resulted in transformant colonies with 85% HDR
efﬁciency.[39] The efﬁcient HR along with Cas9 nuclease
obtained by this approach is a promising step towards high
throughput genome engineering of T. pseudonana.5. Cyanobacteria
The tractability of a prokaryotic organism combined with the
photosynthetic capability of eukaryotic microalgae, promises
cyanobacteria as a potential cell factory. The efﬁcient conversion
of solar energy into biomass, and requirement of low levels of
carbon dioxide compared to eukaryotic microalgae result in high
growth rates. Moreover, the transformation efﬁciency, some-
times exploiting natural competence, further elevates the
possibilities of evolving selected cyanobacterial strains into a
platform organisms for producing biofuels and green chem-
icals.[40] The application of CRISPR-Cas9 based genome
engineering in cyanobacteria was ﬁrst reported for Synechocystis
sp. PCC 6803 where the inactive dCas9 was implemented for
target gene downregulation.[41] Apart from successful single
knockdown of genes coding for GFP, polyhydroxyalkanoate
synthase and ADP-glucose phosphorylase with varying efﬁcien-
cies, simultaneous knockdown of up to four genes coding for
putative aldehyde dehydrogenases/reductases were alsoBiotechnol. J. 2018, 1700591 1700591 (6 of 9) © 2018 Theachieved in this species.[41] CRISPRi-mediated gene down-
regulation has also been reported for Synechococcus elongatus
PCC 7942 where the expression of an exogenous eYFP gene has
been suppressed down to 1% of the control, and the expression
of an endogenous gene glgC down to 6%.[42] Two genes encoding
subunits of the succinate dehydrogenase (sdhA and sdhB) were
also down-regulated to 19 and 33% compared to control levels
resulting in an approximate 12.5% increase in succinate
production.[42] Once the activity of CRISPRi in Synechococcus
sp.PCC 7002 was conﬁrmed by downregulating the heterologous
YFP expression to 0.02% of the control, native genes encoding
subunits of the Phycobilisome (cpcB) and the Carboxysome
(ccmK1) were successfully downregulated.[43] The moderate
repression of the glutamine synthetase I (glnA) gene by CRISPRi
doubled the lactate production in strain PCC 7002, through a
series of metabolic processes enhancing the ﬂux of carbon
towards pyruvate.[43] In Anabaena sp. PCC 7120, the glnA gene
was downregulated by 80% using the CRISPRi, resulting in
accumulation of ammonium.[44] The devH gene essential for
heterocyst development in PCC 7120 was also repressed using
CRISPRi, completely abolishing the growth under nitrogen
ﬁxing conditions.[44] The cytotoxic effects of Cas9 protein was
observed in strains UTEX 2973 and PCC 7942 of the species
Synechococcus elongatus.[45,46] The constitutive expression of the
Cas9 protein was found to be toxic in UTEX 2973 even at the
minimal levels; this problem was overcome by expressing the
Cas9 protein from a vector that cannot replicate at optimal
temperature of Synechococcus, and thereby facilitating Cas9
expression only during a limited period after transformation.
Absence of NHEJ in most prokaryotes in the event of DSB
caused by Cas9 is generally lethal, unless a HDR based repair
template is provided. Therefore, an upstream and downstream
homologous regions of the target gene were incorporated into
the plasmid, allowing for homologous recombination-based
removal of a target gene, and counter-selecting of wild type cells
by Cas9.[46] This approach resulted in successful knock out of
nblA gene involved in degradation of photosystem-associated
proteins with 100% efﬁciency.[46,47] In strain PCC 7942, the
activity of Cas9 in inducing DSB resulting in cell death was
conﬁrmed upon observing proportional reduction in trans-
formants with increase in the dosage of plasmid harboring Cas9
and sgRNA targeting the host genome for transformation . In
line with the observationmade in other organisms, theHDRwas
found to be enhanced in PCC 7942 by the induction of DSB by
Cas9.[6,18,45] This Cas9-assisted HDR was used for metabolic
engineering of PCC 7942 by knocking in genes coding for
phosphoenolpyruvate carboxylase and citrate synthase to
enhance the carbon ﬂux towards oxidative pathway of TCA
cycle. Combining these knock-ins with the knock-out of the
glucose-1-phosphate adenylyl transferase gene to block the
conversion of glucose to glycogen, to increase the carbon ﬂux
towards the glycolysis, resulted in an 11-fold increase in
succinate titer.[45]
The toxicity of Cas9 was the bottleneck that restricted wide
application of this system in cyanobacteria for genome
engineering.[46] Replacement of Cas9 with Cas12a considerably
solved these problems.[48] Cas12a has been successfully
employed for obtaining marker-less mutants of various
cyanobacterial species including Synechococcus elongatus UTEXAuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
www.advancedsciencenews.com www.biotechnology-journal.com2973, Synechocystis sp. PCC 6803 and Anabaena sp. PCC 7120.[48]
Homologous ﬂanks in the upstream and downstream part of the
target region (both 1kb) were introduced into the same vector
expressing the Cas12a and a crRNA guide was used for HDR
based generation of mutants followed by counter selection with
Cas12a. Sanger sequencing and PCR of the target site followed
by phenotypic characterization conﬁrmed the mutants with
knock-ins, knock-outs, and point mutations. In Synechococcus, a
point mutation in the codon of the psbA1 gene (S246A) was
achieved among 25% of the colonies screened initially; re-
streaking the eight colonies thrice in media with antibiotic to
maintain the plasmid resulted in 75% of the colonies having the
desired genotype.[48] A similar observation was made during
knocking in the YFP gene, where initially 20% of the colonies
were segregated mutants and re-streaking the colonies twice on
appropriate antibiotic plates yielded 60% mutant colonies. Also,
the deletion of nblA gene resulted in 90% segregated mutants
after three generations of re-streaking.[48] In Synechocystis, the
efﬁciency of obtaining nblA gene deletion was comparatively
reduced (45%), probably due to the high ploidy level in this
species (up to 50 chromosomes per cell), and to the presence of
two adjacent copies of the target gene on each chromosome.[49]
Introduction of a point mutation in the isiA gene and a gene
insertion by replacement of nblA gene with YFP was achieved
with very high efﬁciency in Synechocystis where 85% of the
obtained colonies were segregated mutants.[48] In Anabaena,
deletion of ﬁrst 400 bps of the nifH gene yielded the designed
mutants in 60% of the colonies. Likewise, point mutation of the
nifD gene and replacement of nifH gene with YFP resulted in
60% segregated mutants.[48]6. Conclusions
Genome editing in a wide variety of species has been simpliﬁed
with efﬁcient and successful application of the CRISPR-Cas
technology. However, the cytotoxic effects of the Cas9 nuclease
has been a hurdle in exploiting the complete potential of this
system in at least some of the microalgal species.[4,16,19,30,35,45,46]
In Chlamydomonas, the Cas9 was inferred to be toxic in
transformants based on unsuccessful detection of even weak
expression of the (intact) Cas9/dCas9-encoding genes.[4] The
molecular basis of this cytotoxic effect of Cas9 has been proposed
to be off target cleavage of host genome. Nevertheless, this does
not explain observations on inhibitory effects of dCas9, a
catalytically inactive Cas9 variant. In another study, however, the
successful expression of dCas9 was achieved under the same
promoter and terminator for downregulation of various
genes.[22] Whereas the former study used a Chlamydomonas
codon-optimized dCas9-encoding gene, the latter study used a
15% different Zea mays codon-optimized sequence.[4,22] This
observation indicates the importance of factors such as codon
harmonization to improve functional protein production. Add-
ing to the proposed Cas9 cytotoxicity, the diminished expression
of Cas9 due to yet unknown factors might be responsible for the
feeble efﬁciency of the tool as observed in C. reinhardtii and
N. oceanica. Moreover, the presence of introns and their role
in regulating gene expressions in eukaryotes could also be
detrimental, e.g., the genome of Chlamydomonas contains aboutBiotechnol. J. 2018, 1700591 1700591 (7 of 9) © 2018 The8.5 introns per gene.[50] Similarly, genomes from micro-algae
such as Nannochloropsis, Phaeodactylum and Thalassiosira
contain 1.7, 0.8 and 1.5 introns per gene, respectively.[28,51]
The introduction of introns into the coding sequence of some
exogenous proteins has been reported to considerably enhance
the expression in Chlamydomonas[52]; hence, the introduction of
introns could contribute to improved functional Cas9 produc-
tion. Also, fusing an antibiotic resistance gene to a heterologous
gene via a self-cleaving 2A peptide sequence and subsequent
selection on antibiotic plates has resulted in transformants with
up to 100-fold increased levels of heterologous protein
production.[53] This strategy could be employed for alleviating
Cas9 expression and thereby increase the efﬁciency of generat-
ing mutants.
Because the efﬁciency of implementing plasmid-based Cas9
for genome editing in microalgae was minimal, a breakthrough
has been the delivery of RNPs by electroporation.[19,23,24]
However, in cyanobacteria the toxicity problem of Cas9 was
solved substantially by replacing it with Cas12a which at least in
some cases has resulted in successful genome editing.[48] The
ability of Cas12a to process its own crRNA guides has been
exploited for efﬁcient multiplex gene editing in various
species.[12,54] These results indicate the possibilities of expand-
ing Cas12a into the micro-algae for efﬁcient and high-
throughput genome engineering. Apart from the SpCas9 and
Cas12a other variants of CRISPR systems which could possibly
emerge as genome editing tools were reviewed recently.[55] The
improved performance of SaCas9 compared to SpCas9 in C.
reinhardtii[19] also indicates the possibilities of applying different
unexplored variants of Cas9 and Cas12a to assess their
functionality and toxicity effects. The recent characterization
of thermostable Cas9 variants may provide a platform for
genome engineering of cyanobacterial species adapted to
extreme conditions.[56] It is important to realize that the potential
of CRISPR systems is not conﬁned to the widely used Cas9, and
that extending engineering studies of model and non-model
strains by using distinct Cas nuclease variants could further
expand the toolbox for genome engineering of photosynthetic
microorganisms and revolutionizing their development as
industry-relevant cell factories.Abbreviations
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I. Makałowska, H. Watanabe, W. Makałowski, Biol. Direct 2016,
11, 35.
[51] S.W. Roy, D. Penny,Mol. Biol. Evolution 2007, 24, 1447; C. Bowler, A. E.
Allen, J. H. Badger, J. Grimwood, K. Jabbari, A. Kuo, U. Maheswari, C.
Martens, F. Maumus, R. P. Otillar, Nature 2008, 456, 239.
[52] V. Lumbreras, D. R. Stevens, S. Purton, Plant J. 1998, 14, 441.
[53] B. A. Rasala, P. A. Lee, Z. Shen, S. P. Briggs, M. Mendez,
S. P. Mayfield, PloS ONE 2012, 7, e43349.
[54] M. Wang, Y. Mao, Y. Lu, X. Tao, J.-K. Zhu,Mol. Plant 2017, 10, 1011.
[55] J. Murovec, Z. Pirc, B. Yang, Plant Biotechnol. J. 2017, 15, 917;
S. Nakade, T. Yamamoto, T. Sakuma, Bioengineered 2017, 8, 265.
[56] L. B. Harrington, D. Paez-Espino, B. T. Staahl, J. S. Chen, E. Ma,
N. C. Kyrpides, J. A. Doudna, Nature Commun. 2017, 8, 1424; I.
Mougiakos, P. Mohanraju, E. F. Bosma, V. Vrouwe, M. F. Bou, M. I.
Naduthodi, A. Gussak, R. B. Brinkman, R. Kranenburg, J. Oost,
Nature Communications 2017, 8, 1647.Authors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
